CTIS.eu › Cities › Spain › Barcelona
Barcelona
Spain
3,391 total trials
1,343 recruiting
Filter these 3,391 trials by phase, condition, sponsor and more.
Open in Search →
2023-509969-20-00
1
2017-07-24
Part C: advanced or unresectable STs (Spain only)
2023-508925-29-00
1
2017-06-29
Advanced solid tumors
2022-501251-81-00
5
2017-06-08
Renal cell carcinoma
2022-501784-40-00
5
2017-05-26
Untreated Unresectable or Metastatic Urothelial Cancer
2024-514999-41-00
4
2017-04-28
HER2 negative metastatic breast cancer (MBC) with nervous system invol
2023-507271-21-00
5
2017-04-11
Follicular Lymphoma
2022-501360-18-00
5
2017-03-15
Early Stage Non-Small Cell Lung Cancer (NSCLC)
2022-501382-49-00
5
2017-03-07
Triple Negative Breast Cancer (TNBC)
2024-511967-26-00
5
2016-11-21
AL Amyloidosis (Newly Diagnosed Systemic AL Amyloidosis)
2023-507294-18-00
5
2016-09-16
Metastatic renal cell carcinoma
2023-508010-42-00
5
2016-09-14
Homologous recombination deficiency advanced ovarian cancer
2024-511235-10-00
5
2016-07-25
Generalized mantle cell Lymphoma
2024-512003-39-00
4
2016-07-18
Lung Cancer
2022-502667-38-00
4
2016-06-20
Solid tumors harboring NTRK fusion
2023-509360-24-00
5
2016-06-16
Subjects with resected adenocarcinoma or squamous cell carcinoma esoph
2024-515394-10-00
9
2016-04-26
Selected Advanced Solid Tumors
2024-516132-10-00
4
2016-02-05
Metastatic breast cancer
2023-509137-39-00
5
2015-11-06
Stage IB (T ≥ 4 cm), II and IIIA NSCLC
2023-508067-70-00
9
2015-04-15
Neoplasms by site
2024-517856-36-00
5
2015-03-09
Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce
2023-504034-22-00
5
2014-12-18
Chronic Lymphocytic Leukemia (CLL)
2023-504761-23-00
5
2014-11-19
Advanced or metastatic renal cell carcinoma
2024-518931-12-00
4
2014-05-15
Neuroblastoma
2023-506419-16-00
5
2013-01-08
Advanced Classical Hodgkin Lymphoma
Showing 3,313–3,336 of 3,391 trials